
Interim results from AUS-PREDICT registry show a significant change in radiation treatment recommendations when using DCISionRT test
DCISionRT is a novel molecular test that assesses the 10-year risk of recurrence after Breast…
GenesisCare is the largest provider of cancer care in Australia, the United States, the United Kingdom and Spain, and is the leading provider of cardiovascular and sleep treatment throughout Australia. We consist of 5,500 highly trained healthcare professionals and support staff across Australia, the U.K., Spain and the United States, designing innovative treatments and care for people with cancer and heart disease. We provide radiation therapy for more people globally than any other care provider. Across our network, we see more than 400,000 people at more than 440 locations.
DCISionRT is a novel molecular test that assesses the 10-year risk of recurrence after Breast…
Integrative oncology can best be described as patient-centred, evidence-based comprehensive cancer care that includes conventional…
GenesisCare, the largest provider of integrated cancer care in Australia, has today welcomed a raft…
GenesisCare is announcing that for the first time, Australian women with non-invasive breast cancer will…
Radioligand therapy, using targeted prostate-specific membrane antigen (PSMA) compounds, is emerging as a promising treatment…